et al.. Removal of a wide range of emerging pollutants from wastewater treatment plant discharges by micro-grain activated carbon in fluidized bed as tertiary treatment at large pilot scale. Science of the Total Environment, Elsevier, 2016, 542,
). In particular, pharmaceuticals and hormones (PPHs), preservatives from personal care 12 products (PCPs), pesticides, phthalates or artificial sweeteners are quantified at ng/L to µg/L levels. These compounds 13 are harmful for the aquatic environment and/or humans (Bolong et al. 2009 , Daughton and Ternes 1999) . In all samples, conventional wastewater quality parameters were analyzed by the SIAAP laboratory, which is accredited 2 by the French authorities (COFRAC), to characterize the overall quality of the water. The monitored parameters are the 3 dissolved organic carbon (DOC), chemical oxygen demand (COD), biological oxygen demand in 5 days (BOD5), UV 4 absorbance at 254 nm (UV-254), total Kjeldahl nitrogen (TKN), NH4 + , NO2 -, NO3 -, total phosphorus (TP), PO4 3and 5 total suspended solids (TSS). The limits of quantification (LQ) and the analytical standards are given in supporting 6 material - Table S2 . In addition, UV-254 and DOC were used to calculate the SUVA (specific UV absorbance = 100 x 7 UV-254/DOC) for every sample to assess the evolution of the organic matter aromaticity. 8 9 A total of 119 priority and emerging pollutants were monitored in the dissolved phase (Table 1 ). The detailed list of the 10 studied compounds is given in supporting material - Table S3 with their limits of detection (LD) and quantification 11 (LQ). The analyses were performed by the Institute of Analytical Sciences (ISA -Villeurbanne, France) of CNRS (n = 12 83; n for the number of compounds), the Laboratory of Water Environment and Urban Systems (LEESU -Créteil, 13
France) (n = 15), the Laboratory CARSO (Poitiers, France) (n = 13), the Central Laboratory of the Police Prefecture 14 (LCPP) (n = 4) and the Water Technology Center (TZW -Karlsruhe, Germany) (n = 4). 15
16
The 83 compounds from ISA were analyzed in all samples and include 5 analgesics, 31 antibiotics, 2 beta blockers, 1 17 diuretic, 10 hormones, 2 hypolipemiants, 4 psychoactive drugs, 3 chlorinated solvents, 2 perfluorinated acids (PFAs) 18 and 23 pesticides (Table 1) . The remaining compounds (n = 36) were analyzed for 6 to 8 campaigns during stabilized 19 phase (supporting material - Table S3 ). The detail of the campaigns performed for each compound is given in 20 supporting material - Table S3 . for the others. These analytical methods were revalidated with the Seine Centre discharges matrix, resulting in updated 24 LD and LQ. For the other substances (LEESU, LCPP and TZW), the detailed methods are given in (Gasperi et Total micropollutants 119 a n = number of substances. b N = number of campaigns performed. c SPE = solid phase extraction. d Analytical methods: LC = liquid chromatography, GC = gas chromatography, GC-MS = GC with mass spectrometry, LC-MS/MS = LC with tandem mass spectrometry. e LQ = limit of quantification. 1 2
Data treatment and presentation 3 4
For the evaluation of the pilot efficiency to remove micropollutants, only the campaigns sampled in stabilized phase 5 were considered. Removals were calculated only when the compounds were quantified in the pilot influents. Thus, two 6 cases were encountered regarding the pilot effluent concentrations: i) the compound was also quantified in the pilot 7 effluents and ii) the compound concentration in the pilot effluents was below LQ or LD. In the first case, removals were 8 normally calculated. In the second case, the removal was estimated by considering a concentration of LQ/2 in the pilot 9 effluents. 10 1 As the number of data for micropollutant concentrations in stabilized phase is relatively limited for both assessed µGAC 2 doses (n = 5 for 20 gµGAC/m 3 ; n = 5 for 10 gµGAC/m 3 ), it was chosen to present all the calculated removals for a 3 compound on the same figure. In tables, only the stabilized phase was considered and average ± standard deviation (SD) 4 with minimum and maximum values are presented. Average ± SD were calculated for compounds with at least 3 values. 5
For the others, only minimum and maximum values are presented. 6 7
In order to evaluate the evolution of the pilot performances on micropollutants, the average removal of the 13 PPHs 8 detected at high occurrences in the WWTP discharges, both in µGAC and PAC configurations, was considered to 9 compare the results in µGAC and PAC configurations. The concentrations of the conventional wastewater quality parameters are given in Table 2 . In the pilot influents, the 19 quality of water is relatively good, particularly for organic matter. Low concentrations are measured for DOC (6.9 ± 1.6 20 mgC/L), COD (27 ± 16 mgO2/L) and BOD5 (3.8 ± 1.8 mgO2/L). Organic matter is particularly important in the 21 adsorption processes because it competes with micropollutants for adsorption sites and/or prevents them from accessing 22 to them by pore blocking ( Regarding the other parameters (Table 2) , TSS (4.7 ± 2.6 mg/L) are very low in the Seine Centre discharges resulting 5 from the high removal (98%) achieved by this WWTP (Mailler et al. 2014 ). For the same reason, 6 nitrogen species concentrations are limited, especially for NH4 + (0.5 ± 0.4 mgN/L), highlighting the total nitrification 7 performed. Low levels of NO2 -(1.04 ± 0.76 mgN/L) and NO3 -(9.7 ± 2.7 mgN/L) were also observed as a result of the 8 efficient denitrification step. Finally, total phosphorus and PO4 3are most of the time found below their LQ, respectively 9 0.3 and 0.1 mgP/L ( The remaining compounds (n = 10) have been quantified at moderate occurrences (25-75%), including bezafibrate, 19 estrone, iopamidol, naproxen or tetracycline. Moreover, 30 PPHs were never quantified in the pilot influents, including 20 20 antibiotics, 7 hormones, fenofibrate, fluvoxamine and primidone. The complete list of these molecules is given in 21 Table 2 . 22
23
Regarding concentrations in the pilot influents (Table 2) naproxen (449 ± 120 ng/L), ofloxacin (953 ± 438 ng/L) or oxazepam (239 ± 110 ng/L). 7 substances have particularly 5 high concentrations (> 1 000 ng/L): diclofenac (1 120 ± 1 400 ng/L), gabapentin (2 360 ± 1 470 ng/L), 6 sulfamethoxazole (1 430 ± 1 450 ng/L) and 4 of the 5 studied X-ray agents. Among the X-ray agents, iohexol (8 600 ± 7 5 130 ng/L) and iomeprol (28 600 ± 16 900 ng/L) concentrations are significantly higher than those observed for the 8 other PPHs. Overall, a group of 13 compounds (Table 2) is characterized by both a high occurrence (> 75%) and lies in 9 the 100 to > 1 000 ng/L range in the pilot influents. These substances have to be carefully considered in the 10 performances evaluation, especially for comparing with other tertiary treatments. (Table  22 2), what is favorable to micropollutant removal. However, several differences can be identified. For example, higher occurrence than in the study of (Margot et al. 2013 ), which studied a tertiary PAC treatment at large scale with a 27 high number of campaigns. These differences should result from differences of countries consumptions and/or a specific 28 behavior of these compounds within the biofiltration process. 29 30 1 Other emerging pollutants 2 3 28 compounds (in 57) were never quantified, i.e. butyl benzyl phthalate (BBP), benzyl paraben, chlorinated solvents (n 4 = 3), cyclamate and pesticides (n = 23). 5 29 other emerging pollutants (in 57), including 6 priority substances from (EC 2013), were quantified in the pilot 6 influents ( Table 2) . AMPA, benzotriazole, bisphenol A, DEHP, DnBP, ethyl paraben, glyphosate, methyl paraben, 7 triclosan and triclocarban, as well as 5 alkylphenols (4-NP, NP1EO, NP2EO, NP1EC and t-OP) and 3 sweeteners 8 (acesulfame, saccharin and sucralose) were found at high occurrences (> 75%), while butyl paraben, OP2EO, PFOA, 9
PFOS and propyl paraben were quantified at low occurrences (< 25%). The remaining pollutants (n = 9) have a 10 moderate occurrence (25-75%), including priority substances diuron and terbutryn. During the ramp-up phase, the performances of the pilot were assessed using UV-254 and COD. UV-254 is a 5 parameter that is very easy and quick to measure either in continuous (sensor) or in punctual (spectrophotometer 6 UV-Vis). Since a good correlation between UV-254 and several micropollutant removals has been highlighted in which are a fraction of the organic matter (DOC). The relation suggests that both the aromatic and the non-16 aromatic fractions of the organic matter are adsorbed. However, the aromatic fraction is better removed than the 17 whole organic matter, as the UV-254 removal is always higher than the DOC removal. This is confirmed by the 18 SUVA (specific UV absorbance) which is always lower in the pilot effluents (2.0 ± 0.4 L/(mgC.m)) than in 19 influents (1.7 ± 0.3 L/(mgC.m)) of the pilot. In addition, the removal increase of the aromatic fraction is similar 20 to the removal increase of the whole organic matter, as highlighted by the linear relation. 21
22
The 13 PPHs (in bold in Table 2) found at a high occurrence (> 75%) in the pilot influents in both PAC and 23 µGAC configurations of the pilot (Figure 1) were selected as an indicator of the process performances. The 24 correlation found between UV-254 and the average removal of these 13 PPHs is also significant (p-value < 25 0.0001) and strongly positive (rSpearman = 0.948). Unlike the previous correlation, this one is logarithmic, 26
highlighting that PPHs and organic matter have a different affinity for activated carbon, especially at low UV-27 254 removals. Similar significant (p-value < 0.0001) correlations are found between UV-254 and several 28
individual PPHs (supporting material - Figure S5 ) such as atenolol (rSpearman = 0.926), carbamazepine (rSpearman = 29 0.821), diclofenac (rSpearman = 0.900) or trimethoprim (rSpearman = 0.766). This indicates that UV-254 removal is a 1 good proxy of the PPHs removal and can then be used as a performances indicator for tertiary treatments.. Online monitoring of UV-254 (sensors) was used for the determination of the optimal µGAC retention time (SRT). As 3 UV-254 removal is well correlated to the PPHs removal (Figure 1) , it was used to evaluate the overall performances of 4 the pilot during the ramp-up phase. Figure 2 displays the increase of the pilot performances during the ramp-up phase 5 until reaching the stabilized phase. A technical problem with the UV-254 sensors at 20 gµGAC/m 3 prevented to obtain a 6 complete curve for this configuration. The stabilized phase starts when UV-254 removal reaches a plateau: the timing is 7 then determined a posteriori. 8
This SRT is relatively low for PAC in general (5-7 days) but is much higher for µGAC ( Figure 2) , which is composed 9 of particles ten times larger than those of PAC, resulting in significantly slower saturation kinetics for µGAC. after this period of operation with maximum temporary removal variations of 5% between 90 th and 160 th day for both 15 doses. This SRT can then be considered as the optimal SRT, although the effective SRT applied during the study was 16 120 days, and the µGAC shape (total mass of µGAC, concentration and depth of the bed) at this time has to be taken as The removals of conventional wastewater quality parameters within the µGAC tertiary treatment are given in 5 Table 3 . Overall, the quality of the WWTP discharges is improved during µGAC treatments, with removals 6 observed for most of the parameters. The impact on phosphorous pollution was not determined due to the very 7 low levels of PO4 3and TP (< LQ). process to retain a fraction of the particulate pollution. This TSS retention capacity is similar with both doses 18 (Table 3) and is confirmed in supporting material - Figure S4 which displays the TSS concentrations measured 19 by sensors in both influents and effluents of the pilot during the whole study at a time interval of 1 h. As regards 20 the nitrogen species (Table 3) , a clear biological activity is occurring in the reactor in stabilized phase. Indeed, a 21 removal of TKN (42 ± 16 %, both doses considered), NH4 + (47 ± 20 %) and NO2 -(95 ± 1 %) is observed while 22 NO3 -(< 3%) is rather produced. This suggests that nitratation is occurring in the reactor. This is not surprising 23 considering the high SRT (90-100 days) leading to the formation of a biofilm in the reactor. The very high 24 removal of NO2is particularly interesting for WWTP manager since such tertiary treatment could be also used 25
to improve the nitrite treatment and reduce the discharges in the aquatic environment of this problematic 26 regulated parameter. (%) 3  BOD5  57  48  0  29  43  35 ± 22  COD  41  39  44  48  43  43 ± 3  DOC  35  35  36  44  24  35 ± 7  NH4 +  NC  19  19  55 24 ± 1 1 BOD5 = biological oxygen demand in 5 days; COD = chemical oxygen demand; DOC = dissolved organic carbon; TKN = total Kjeldahl nitrogen; TSS = total suspended solids; UV-254 = UV absorbance at 254 nm. 2 Average ± standard deviation. 3 Removal in italics: <LQ in the pilot effluents; NC = not calculated (<LQ in both influents and effluents of the pilot). PPHs quantified and for the average of the 13 PPHs selected as performance indicator. Furosemide is not represented 6 because it was not quantified during stabilized phases (only ramp-up phase). The compounds for which all the removals 7 were estimated (<LQ in the pilot effluents) as previously explained, are marked with an asterisk (*). 8
Overall, while 32 PPHs were quantified in the pilot influents, only 18 were still measured quantified in the pilot 9 effluents at 20 gµGAC/m 3 and 16 at 10 gµGAC/m 3 (Table 2) . 10 4 types of behaviors can be observed within the µGAC treatment: very good (> 80%), good (60-80%), moderate (30-11 60%) and low (< 30%) removals. 12
13
At 20 gµGAC/m 3 , 5 compounds have low removals (< 30%), particularly gabapentin (7-33%; min-max) and 14 sulfadimethoxine (< 0-23%). Iothalamic acid, 17-α-and 17-β-estradiols were very occasionally detected but when 15 detected, the compounds are not or very poorly removed (< 20%). In contrary, 16 PPHs are very well and steadily 16 removed (> 80%) by the process, such as diclofenac (71-97%), ofloxacin (76-90%) or oxazepam (74-91%). Among 1 them, 8 compounds have a particularly high affinity for µGAC (> 90%), i.e. atenolol (92-97%), carbamazepine (80-2 94%), ciprofloxacin (75-95%), estrone (88-90%), ketoprofen (82-95%), lorazepam (95-99%), propranolol (94-98%) and 3 roxithromycin (80-99%). In addition, acetaminophen and ibuprofen are eliminated up to 95%. 5 compounds have good 4 removals (60-80%) with µGAC, including erythromycin (43-77%), iopromide (60-67%) and sulfamethoxazole (56-5 83%) . The remaining PPHs (n = 4) have moderate removals (30-60%). Indeed, bezafibrate (53-55%), iohexol (57-58%), 6 iomeprol (28-37%) and iopamidol (55%) have a moderate affinity for µGAC. The average removal of the 13 PPHs at 7 20 gµGAC/m 3 is around 85% (78-89%). 8 9
At 10 gµGAC/m 3 , the efficiency of the pilot is reduced. The removals of erythromycin (3-47%), iopamidol (9-42%), 10 iopromide (39-57%) and sulfamethoxazole (12-24%) move from moderate or good to low or moderate removals. 11
Similarly, carbamazepine (40-62%), ketoprofen (14-82%) and oxazepam (33-51%) move to the moderate removals 12 category, while ciprofloxacin (70-85%), ofloxacin (58-73%) and roxithromycin (28-73%) are now in the good removals 13 category. In addition, tetracycline, which was not quantified in any campaign of the 20 gµGAC/m 3 configuration, is rather 14 well removed (39-90%). Finally, good or very good removals are still observed for atenolol (51-92%), lorazepam (82-15 99%), norfloxacin (58-86%) and propranolol (77-98%). The average removal of the 13 PPHs at 10 gµGAC/m 3 of fresh 16 µGAC is around 60% (57-68%). Conventional wastewater quality parameters were considered followed by the 13 PPHs quantified at high occurrence 8
( Table 2) , monitored both in µGAC and PAC configurations. Finally, the other emerging pollutants are discussed. 9
10 Conventional wastewater quality parameters 11
12
Regarding conventional wastewater quality parameters, two groups can be distinguished: those impacted (DOC and 13 UV-254) and those not impacted (BOD5, COD, nitrogen species and TSS) by the activated carbon dose (10 or 20 g/m 3 ), 14
whether PAC or µGAC. For the parameters not impacted by the dose applied, the pilot has a similar efficiency with 15 µGAC or PAC, i.e. removals of 38-45% for BOD5. In contrary, COD or nitrogen species are better removed by µGAC, 16
resulting from the biological activity induced by the high SRT, particularly for TKN, NO2and NH4 + ( Figure 5 ). 17
Moreover, TSS were not removed at all by the PAC treatment (Mailler et al. 2015b ), but are efficiently retained by the 18 µGAC bed (Table 3 ). This means that µGAC is able to remove a fraction of the micropollutants in the particulate phase 19
(not monitored in this study), in contrary to PAC. Regarding the parameters impacted by the activated carbon dose 20 (organic matter), UV-254 is similarly removed for both activated carbon configurations at both 10 g/m 3 and 20 g/m 3 . 21
For DOC, a different trend is highlighted as PAC is slightly more efficient than µGAC at similar doses, both at 10 and Different types of behaviors are encountered regarding PPHs removal with PAC or µGAC ( Figure 5 ). First, atenolol, 28 diclofenac and propranolol have very similar removals between µGAC and PAC for the same dose. In contrary, 29 carbamazepine, erythromycin, ketoprofen, norfloxacin and ofloxacin are rather slightly better removed by PAC than 30 µGAC for the same dose, but the differences are limited (< 20%) and not significant. Then, oxazepam and 1 sulfamethoxazole are better removed with PAC at a dose of 10 g/m 3 , but this is not the case anymore at a dose of 20 2 g/m 3 as removals are equivalent between PAC and µGAC. For these compounds, the dose of µGAC seems to have a 3 greater impact than the dose of PAC. Finally, lorazepam and roxithromycin are rather better removed by µGAC than 4 PAC at a similar dose. These tendencies should be taken with caution regarding the limited removal differences. 5
6
Overall, µGAC can be considered as efficient as PAC for PPHs removal at a similar fresh activated carbon dose. 7
Indeed, the average removal of the 13 PPHs is similar with 20 g/m 3 of both PAC (88 ± 4%) and µGAC (81 ± 4%), as 8 well as with 10 g/m 3 of both PAC (68 ± 11%) and µGAC (60 ± 4%). Moreover, by comparing the average removals of 9 the 13 individual PPHs, and as displayed in Figure 5 , the pilot performances are significantly similar between µGAC 10 and PAC operating at a dose of 20 g/m 3 (p-value = 0.218) or 10 g/m 3 (p-value = 0.275). 11
12
The slightly better performances (10-20%) obtained with PAC compared to µGAC for several compounds could be 13 explained by various factors such as the nature of µGAC which is reactivated (loss of sorption sites), in contrary to 14 PAC, or the higher hydraulic velocity with µGAC. However, this is more likely due to the application of FeCl3 in PAC 15 configuration to handle correctly the bed, which improves the colloidal pollution elimination by sand filtration). The CarboPlus® process is based on a high mass fluidized bed of activated carbon with continuous 5 injection of a fresh dose and without any additional separation step. The high efficiency of this technology to remove a 6 wide range of micropollutants has been previously highlighted with PAC (Mailler et al. 2015b) . In this study, the 7 tertiary treatment of WWTP discharges by µGAC has been evaluated for conventional wastewater quality parameters, 8
PPHs and other micropollutants in this study. 9 10 First, the relationships between UV-254, organic matter (DOC) and several PPHs (average removal or individual 11 compound removal) has been confirmed by compiling data from both the PAC and µGAC studies. UV-254 removal is a 12 good proxy of the PPHs removal and can then be used as a performances indicator for tertiary treatments. This 13 parameter is much easier and cheaper to measure than micropollutants. The monitoring of this parameter allowed 14 determining an optimal µGAC retention time of 80-90 days, both at 10 and 20 gµGAC/m 3 . 15
16
The µGAC fluidized bed treatment improves the overall quality of WWTP discharges, with removals of 30-35% for 17 DOC, 40-45% for UV-254, 38-45% for BOD5 and 40-45% for COD. In addition, TSS are strongly retained by the 18 µGAC bed, and nitratation occurs in stabilized phase allowing a total elimination of NO2 -. Regarding micropollutants, 19 µGAC removes PPHs efficiently (> 80%), particularly atenolol, carbamazepine, ciprofloxacine, ketoprofen, lorazepam, 20 ofloxacin, oxazepam or propranolol. Several other PPHs are also substantially removed (> 50%) such as diclofenac, 21 erythromycin, sulfamethoxazole or X-ray agents. Alkylphenols, artificial sweeteners, benzotriazole, bisphenol A, PCPs, 22 pesticides and PFOS have also a good affinity for µGAC, while phthalates are not or poorly eliminated. The fresh 23 µGAC dose is a crucial parameter and greatly influences the pilot performances. Thus, the average removal of the 13 24
PPHs selected as performances indicator reaches 78-89% at 20 gµGAC/m 3 against 57-68% at 10 gµGAC/m 3 . 25
26
Overall, µGAC allows obtaining performances comparable to PAC treatments at a same fresh activated carbon dose, 27 even if slightly higher removals are observed with PAC for several compounds. The differences are explained by the 28 nature of µGAC, which is reactivated, and more likely by the injection of FeCl3 with PAC. However, µGAC removes 29 NO2and TSS, in contrary to PAC. In addition, the µGAC configuration leads to several operational advantages over 30 Delgado, L.F., Charles, P., Glucina, K. and Morlay, C. (2012) The removal of  5  endocrine  disrupting  compounds,  pharmaceutically  activated  compounds  and  6 cyanobacterial toxins during drinking water preparation using activated carbon----
